Investors

AIM Rule 26 Information

This area of the web site contains all information which is required to be disclosed in accordance with Rule 26 of the AIM Rules.

Shareholder Information

Other Exchanges and Trading Platforms
Shares in Issue
Significant Shareholdings
Director Shareholdings
Shares Not in Public Hands
Restrictions in Transfer of AIM Securities
UK City Code on Takeovers and Mergers

see Shareholder Information

Advisors

see Advisors

Announcements and Notifications

see News

Q&A with LungLife AI's CEO, Paul Pagano

Half-year Report For The Six Months Ended 30 June 2023

Featured News

August 15, 2024

Half-year 2024 Notice of Results

LungLife AI, Inc.(the “Company” or “LungLife”) Notice of Results Investor Briefing LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for the early detection of lung cancer, will announce its unaudited half-year report for the six months ended 30 June 2024 on Thursday 22 August 2024. Investor presentation Paul Pagano, Chief Executive Officer, and […]

• Read More

June 5, 2024

Result of AGM

LungLife AI, Inc. ("LungLife" or the "Company") Result of Annual General Meeting LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that at its Annual General Meeting, held at earlier today, all 10 resolutions put to members were passed on a poll. Full details of the voting will be available […]

• Read More

« Previous 1 … 4 5 6 7 8 … 37 Next »

More News